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Abstract 
The accessibility of fluorescently labeled (antigenic) peptides bound to the detergent-solubilized mouse MHC class II protein IEd has been studied 
by fluorescence techniques. Based on the efficiency of fluorescence quenching by the aqueous quenchers iodide and TEMPOL, different degrees of 
accessibility of the peptide-attached fluorescein moiety are distinguished in the IEd-bound state, which depend on the nature of the peptide and on 
the site of attachment. These different extents of sequestration from the aqueous phase are reflected in the fluorescence properties of the corresponding 
NBD-labeled peptides bound to IEd. The results provide information on the topology of class II bound peptides. 
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1. Introduction 
MHC class II proteins are heterodimeric polymorphic 
membrane proteins that bind antigenic peptides and 
present hem to T cells. Recently, the three-dimensional 
structure of the human class II protein HLA-DRl was 
solved by X-ray crystallography [l]. As predicted from 
sequence homology [2], the class II peptide binding site 
is very similar to that of the MHC class I molecule of 
which the crystal structure was determined earlier [3]. 
Both consist of a groove between two parallel a-helices 
which are on top of a continuous eight-strand antiparal- 
lel B-sheet. One important difference between the class 
I and class II binding sites is that the ends of the class 
II groove are more open, allowing the peptides, which 
are bound in an extended conformation, to protrude 
from both ends [l]. This is consistent with the ability of 
class II proteins to bind peptides of variable length [4,5]. 
In contrast, class I proteins bind peptides of a limited 
length of 8-10 amino acids [6], with both the N- and the 
C-terminus of these peptides anchored in the binding 
groove and the amino acids in the middle bulging out 
[7,8]. Apart from X-ray crystallography, 2D NMR tech- 
niques have recently been used to characterize the inter- 
actions and localization of a peptide in the MHC binding 
groove [9]. 
2. Materials and methods 
2.1. Purification of IEd 
Fluorescent labeling of peptides not only enables the 
highly sensitive detection of peptide binding to MHC 
molecules [lo], but can also be applied to study the topol- 
ogy of MHC bound peptides, as will be demonstrated 
here for peptides complexed to the mouse class II mole- 
cule IEd. Using two independent fluorescence methods, 
(i) quenching of fluorescein emission by aqueous quench- 
ers, and (ii) fluorescence nhancement of NBD-labeled 
peptides, it is shown that the peptide-attached labels at- 
tain different micro-environments upon binding to IEd. 
The characterization of the binding to and release from 
IEd of the peptides used in this study has been reported 
[l 11. 
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IEd was purified from a Nonidet P-40 lysate of A20-1 .l 1 cells by 
affinity chromatography using the antibody 14.4.43 according to stand- 
ard procedures [l 11. The detergent NP-40 was replaced by n-dodecyl 
/?-D-maltoside (DM, Sigma, St. Louis, MO) during the washing of the 
affinity column. Subsequently, IEd was eluted using 0.5 M NaCl, 1 mM 
DM, 0.1 M Na,COr pH 11.5. The eluate was immediately neutralized 
to pH 7, concentrated, dialyzed against 150 mM NaCl, 1 mM DM, 10 
mM NaP, pH 7.0 (DM buffer), and stored at 4 “C. The protein concen- 
tration was determined by the Lowry method. 
Abbreviations: MHC, major histocompatibility complex; HEL, hen egg 
lysozyme 107-116; dyn, dynorphin A l-13; TEMPOL, 4-hydroxy- 
2,2,6,6-tetramethylpiperidinyloxy; F, fluorescein; NBD, ‘T-nitro-benz- 
2-oxa-1,3-diazole; ACP, acyl carrier protein 65-74. 
2.2. Synthesis and labeling of the peptides 
The synthesis, HPLC purification, labeling, and characterization of 
the fluoresceinated peptides (F-peptides) used in this study has been 
described [ll]. The peptides hen egg lysozyme 1077116 (HEL, H-AWV- 
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AWRNRCK-OH) and dynorphin A 1-13 (dyn, H-YGGFLRRI- 
RPKLK-OH) were labeled with NBD at the N-terminus while still 
on the resin, by reaction with a 3-fold molar excess of 4-fluoro-7- 
nitrobenz-2-0x&1,3-diazole (NBD-fluoride, Molecular Probes, Eu- 
gene, OR) in dimethylformamide to yield NBDHEL and NBDdyn, 
respectively. The cysteine residue of NBDHEL was carboxamidometh- 
ylated with iodoacetamide to prevent he formation of peptide dimers. 
Alternatively, the cysteine residue at position 115 of HEL 107-l 16 was 
labeled with NBD by reaction with a 3-fold molar excess of N-((2- 
(iodoacetoxy)ethyl)-N-methyl)amino-7-nitrobenz -2- oxa-1,3 diazole 
(IANBD, Mol. Probes) at 1 mg peptide/ml in 0.1 M ammonium-acetate 
pH 8.0 containing 25% v/v acetonitrile, to yield NBDcysHEL. 
The final purity of the peptides was greater than 98%. Peptide stock 
solutions in water were stored in aliquots at -20 “C. The concentrations 
of the peptide stock solutions were determined by quantitative amino 
acid analysis and confirmed by spectrophotometry as described [l 11. 
Both NBDHEL and NBDdyn in PBS exhibited an .=? of 2.2. lo4 
M-’ .cm-‘, and E”~~ of NBDcysHEL was found to be 2.8. lo4 
M-l .cn-’ in agreement with values reported in the literature [12,13]. 
advantage of the high stability of these complexes, fluo- 
rescence quenching experiments were performed on IEd- 
Fpeptide complexes purified by HPSEC. Under the ex- 
perimental conditions used, class II-peptide complex 
preparations with approximately 10% of the class II mol- 
ecules occupied by the fluoresceinated peptide were 
obtained (not shown). The efficiency of quenching by 
aqueous quenchers was compared for the IEd-bound F- 
peptide and a corresponding amount of the free F-pep- 
tide in DM buffer. 
2.3. Preparation of IEd-peptide complexes 
The class II molecules (l-3 PM) were incubated with 50 ,uM of the 
fluorescein (F)- or NBD-labeled peptides in DM buffer at 37 “C for 5 
days. Complexes were separated from the bulk of free peptide by gel 
filtration on Sephadex G-50. For the final purification, the eluate was 
concentrated and applied to a TSK-gel G3000 SW (Tosohaas, 
Montgomeryville, PA) high-performance size exclusion column 
(HPSEC) eluted with DM buffer [l 11. The IEd c$ heterodimer fraction 
was collected and used within a few hours in the fluorescence measure- 
ments. The concentration of the complex was determined from the 
absorbance signal of the LJV detector connected to the column. 
The accessibility of the fluorescein moiety to the colli- 
sional quencher of fluorescein fluorescence iodide [15], 
is reduced when the peptides FHEL and FcysHEL are 
bound to IEd as shown in the Stem-Vohner plot (Fig. 
1 A), with the reduction in I- accessibility of FHEL being 
greater than that of FcysHEL. As the putative binding 
2.4. Fluorescence measurements 
All fluorescence measurements were carried out at room tempera- 
ture, in DM buffer, in a total volume of 1 ml, and under continuous 
stirring, using a Spex Fluorolog fluorimeter. In the fluorescence 
quenching experiments the fluorescence intensity of the IEd-Fpeptide 
complex (cont. 7-10 nM) and of free F-peptide with a corresponding 
fluorescence l vel (0.5-l nM) was recorded after the successive addition 
of small aliquots of quencher stock solutions. The excitation wave- 
length was 490 nm, the emission was read at the peptide’s wavelength 
of maximum emission, which is 526 nm for FHEL and 516 nm for the 
other F-peptides studied. The fluorescence intensity of the complex was 
corrected for background, i.e. the fluorescence intensity of the eluate 
collected from the HPSEC column prior to the IE“ fraction, which 
never exceeded 5% of the total signal. The quencher stock solution was 
either 4 M KI containing 1 mM Na,S,O, to avoid I,- formation, or 0.4 
M 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy (TEMPOL, Aldrich 
Chemical Co., Milwaukee, WI). The quenching data were analyzed 
according to the Stem-Volmer equation, FJF = 1 + KS”. [Q], with F, 
the fluorescence intensity in the absence of quencher Q, F the fluores- 
cence measured at different values of [Q], and K,, the Stern-Volmer 
constant which provides a relative measure for the fluorophor’s acces- 
sibility to the quencher. 
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The antigenic peptide HEL 107-l 16 was labeled with 
fluorescein either at its N-terminus or at Cys115, yielding 
FHEL and FcysHEL, respectively. The modification of 
the Cys residue abrogates the IEd-restricted activation of 
the HEL 107-116 specific T cell hybridoma D2.1E5, 
whereas labeling of the N-terminus does not interfere 
with T cell activation [11,14]. Both fluoresceinated pep- 
tides show a similar extent of binding to detergent-solu- 
bilized IEd, which results in IEd-peptide complexes with 
half times of dissociation at pH7, 37°C of 100 h and 200 
h for FcysHEL and FHEL, respectively [ll]. Taking 
10 
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Fig. 1. Stem-Volmer plots of quenching by iodide (A) and TEMPOL (B) 
of FHEL (triangles) and FcysHEL (circles) bound to IEd (solid symbols) 
and in DM-buffer (open symbols). The concentration of the IEd-peptide 
complexes is in the range of 7-10 nM, that of the free peptides in the 
range of 0.5-l nM. For experimental details see section 2. 
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Fig. 2. (A) Fluorescence mission spectra of NBDHEL in DM-buffer 
(short dashes) and bound to IEd (long dashes), of NBDcysHEL in 
DM-buffer (thin line) and bound to IEd (thick line), and of(B) NBDdyn 
in DM-buffer (short dashes) and bound to IEd (long dashes). The 
concentration of the IEd-peptide complexes is 40 nM. In view of the 
poor signal-to-noise ratio, the spectra of the complexes were smoothed. 
Spectra of the free peptides in DM-buffer were recorded at 50 nM and 
depicted after normalization to 4 nM to enable comparison with the 
spectra of the IEd-bound peptides, which are estimated to oc- 
cupy - 10% of the IEd molecules (see text), assuming that the binding 
of NBD- and fluorescein-labeled peptides is similar. 
groove of IEd is lined with negatively charged amino acid 
residues [161, this reduced quenching may be due to elec- 
trostatic repulsion of the anionic I- [17]. Therefore the 
experiment was repeated using the uncharged nitroxide 
radical TEMPOL, which quenches fluorescein fluores- 
cence very efficiently by a mechanism involving electron 
exchange [18]. Although the decrease in TEMPOL 
quenching efficiency relative to the free peptide is 
smaller, the decreased accessibility of the IEd-bound pep- 
tides to TEMPOL parallels that to I- (Fig. 1). 
In Table I the values of the Stern-Volmer constants 
Ks, of several peptides in the IEd-bound state and free 
in solution have been summarized with the residual ac- 
cessibility to the quenchers calculated as the ratio of 
K bo”nd/Ksvfree. The disulfide-bridged dimer of HEL 
ll;-116 was previously shown to compete for binding 
to IEd with F(cys)HEL, and to displace prebound pep- 
tides from IEd. Complexes of its fluoresceinated ana- 
logue FHELsSHEL with IEd have intermediate stability 
compared to the FcysHEL- and FHEL complexes [111. 
Quenching of this complex with TEMPOL reveals that 
the residual accessibility of the fluorophor in the IEd- 
bound state is virtually the same as that in the FHEL-IEd 
complex (Table 1). Under the reasonable assumption 
that one of the HEL 107-l 16 sequences in the dimer uses 
the same anchoring site(s) in the binding groove as the 
monomer [ll], this result implies that there is a prefer- 
ence for the fluoresceinated N-terminus over the open 
one to take this position. 
The fluorescein attached to the N-terminus of the pep- 
tide dynorphin A 1-13 (Fdyn) also shows strong seques- 
tration from the aqueous phase upon binding to IEd 
(Table 1). Although not known as an IEd-restricted anti- 
genie peptide, dynorphin was shown to specifically bind 
to IEd resulting in a stable complex (t,,, - 50 h at 37”(Z), 
and to be very effective in displacing peptides from pre- 
formed IEd-peptide complexes [11,19,20]. 
As a control the quenching of the randomly chosen 
peptide FACP was examined. The unlabeled analogue 
ACP (acyl carrier protein 65-74: H-VQAAIDYING- 
OH) does not compete for binding to IEd with 
F(cys)HEL, neither does unlabeled HEL compete with 
FACP [ll]. The low level but long-lived (tl,* - 100 h at 
37 “C) association of FACP with IEd detected with 
HPSEC was therefore attributed to non-specific binding 
outside the binding groove. Accordingly, no significant 
difference in accessibility to TEMPOL was detected for 
FACP free in solution or associated with IEd (Table 1). 
Besides fluorescein-labeled peptides, also peptides la- 
beled with NBD have been used to detect peptide binding 
Table 1 
Stern-Vohner constants of quenching (Ksv) by iodide and TEMPOL 
of the fluoresceinated peptides bound to IEd, free in DM-buffer, and 
their ratio 
Iodide TEMPOL 
Peptide KsVboUnd KS,‘” KSVboUnd KSVboUnd KS,‘- KSVboUnd 
CM-‘) (M-l) Ksvf”’ (M-‘) (M-l) KS? 
FHEL 3.6 8.9 0.40 14.3 20.5 0.70 
FcysHEL 6.9 9.1 0.76 18.1 20.7 0.87 
FHEL”s - _ _ 13.6 19.5 0.70 
HEL 
Fdyn 2.8 8.5 0.33 15.9 24.0 0.66 
FACP’ - _ _ 15.4 15.9 0.97 
‘In view of the low level of association of the control peptide FACP with 
IEd, the concentration of complex used in this experiment was 40 nM. 
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to MHC molecules [21]. In contrast to fluorescein, the 
fluorescence characteristics of NBD are dependent on 
the polarity of the surrounding medium [12]. As the envi- 
ronment becomes more apolar (smaller dielectric con- 
stant) the emission quantum yield of NBD increases 
while the wavelength of maximum emission decreases. 
Using the NBD-labeled analogues of HEL 107-l 16 and 
dynorphin, the effects of binding to IEd on the NBD 
emission spectra were examined. In Fig. 2 the emission 
spectra of NBDHEL, NBDcysHEL, and NBDdyn com- 
plexed to IEd are compared to those of the corresponding 
amounts of the free peptides in DM buffer. The wave- 
length of maximum emission and the quantum yield of 
NBDcysHEL are higher than those of both N-terminally 
labeled peptides which is probably due to the different 
chemistry by which the fluorophores are coupled. 
Upon binding to IEd, both N-terminally labeled pep- 
tides exhibit a strong enhancement in fluorescence inten- 
sity, indicating that the NBD label has entered a less 
polar environment. In contrast, the fluorescence inten- 
sity of NBDcysHEL does not significantly change, indi- 
cating that the NBD label stays in a polar environment 
when bound to IEd. The weak fluorescence signal from 
the complexes does not allow conclusions about possible 
shifts in emission wavelength (see legend to Fig. 2). 
The results obtained using the NBD-peptides are con- 
sistent with the quenching data. Although the cysteine- 
attached fluorophore of HEL 107-l 16 becomes less ac- 
cessible to the aqueous quenchers upon binding to IEd, 
the data obtained with NBDcysHEL indicate that the 
label at this position does not enter a more apolar envi- 
ronment. Probably the interaction of the peptide with the 
IEd binding groove results in some extent of steric shield- 
ing of the fluorophor from the quenchers while leaving 
the local dielectric constant experienced by the fluoro- 
phor unaffected. Taking into account the inability of 
both FcysHEL [l l] and NBDcysHEL (not shown) to 
elicit IL-2 production by an HEL 107-l 16 specific T cell 
hybridoma, it is concluded that the cysteine-attached 
label of HEL 107-116 bound to IEd is exposed to the 
aqueous phase. 
The analysis of HEL 107-l 16 analogues with single 
amino acid substitutions has revealed that the three pos- 
itively charged residues at positions 112, 114, and 116 
determine the peptide’s capacity to bind to IEd [19]. The 
results of the present study indicate that the fluorescent 
label attached at the opposite end of the molecule, at the 
N-terminus, becomes at least partially sequestered from 
the aqueous phase. Interestingly, the nature of the resi- 
due at this position is not important for the interaction 
with IEd [19]. The N-terminus of dynorphin appears to 
attain a similar localization. The data point to a struc- 
tural model in which the N-termini of HEL and dyn are 
buried in, rather than protruding from, the IEd binding 
groove. In this respect he IEd-peptide complexes tudied 
here, differ from the complex of IEk with the moth cyto- 
233 
chrome c 88-103 peptide where the N-terminus was 
shown to extend out of the binding groove [9,17]. Given 
the ability of the class II binding groove to accomodate 
a stretch of approximately 15 amino acid residues [11, the 
shorter lengths of HEL and dyn compared to the cyto- 
chrome c peptide may account for this difference. 
In a previous study in which an anti-fluorescein anti- 
body was used as quencher, the authors were not able to 
detect any differences in accessibility of fluorescein labels 
attached at various positions, including the N-terminus, 
of the peptide OVA 323-339 bound to IAd [22]. The 
discrepancy between these results and the data presented 
here may be due to the different nature of the quenchers 
used. TEMPOL and iodide do not irreversibly interact 
with fluorescein like the antibody and therefore report 
more reliably on the time-averaged exposure of the fluo- 
rescein probes to the aqueous phase. 
In conclusion, the straight-forward technique of fluo- 
rescence quenching of fluoresceinated peptides com- 
plexed to MHC molecules, which requires only small 
amounts of peptide and protein, provides information on 
the structure of these complexes that may complement 
the more elaborate crystallographic and 2D NMR stud- 
ies. 
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